An exploratory study to examine the health benefits of the continuous drink of olive tea: a randomized, parallel group, controlled trial.

An exploratory study to examine the health benefits of the continuous drink of olive tea: a randomized, parallel group, controlled trial. - Continuous drink study of olive tea

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000020321

Enrollment

Registered

2015-12-24

Start date

2016-01-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy subjects

Interventions

Olive tea(1L/d*12 weeks) Green tea(1L/d*12 weeks)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Aged 40 -70 years. 2)LDL-cholesterol not less than 120 mg/dL, under 160 mg/dL 3)Capable of giving informed consent

Exclusion criteria

Exclusion criteria: 1)Body mass index not less than 30.0 kg/cm2 2)Fasting blood glucose not less than 126 mg/dL 3)HbA1c not less than 6.5% 4)Subjects who are received pharmacotherapy for alimentary disease 5)No enrollment in another interventional study 6)Subjects who were recognized unsuitable for this study by the Investigator.

Design outcomes

Primary

Measure	Time frame
Lipid metabolic indicator after 12-week intervention	—

Secondary

Measure	Time frame
1.Body weight, Abdominal circumference 2.Blood pressure 3.Glucose metabolic indicator 4.Hepatic and renal function indicator 5.Bone turnover marker	—

Countries

Japan

Contacts

Public ContactKoichi Hashimoto

University of Tsukuba, Faculty of Medicene Clinical research and regional innovation donated by the JA Ibaraki Public Welfare Federation

koichi.hashimoto@md.tsukuba.ac.jp029-853-3064

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026